<scp>AI</scp>‐Based Platelet‐Independent Noninvasive Test for Liver Fibrosis in <scp>MASLD</scp> Patients
This AI model accurately assesses liver fibrosis in MASLD patients without requiring platelet count or elastography. Its simplicity, cost-effectiveness, and strong diagnostic performance make it well-suited for large-scale health screenings and routine clinical use.
Authors
- Shun‐ichi Wakabayashi (ORCID: https://orcid.org/0000-0002-4657-4785)
- Nobuharu Tamaki
- Takanobu Iwadare (ORCID: https://orcid.org/0000-0003-0430-6819)
- Yūki Yamashita (ORCID: https://orcid.org/0000-0002-0162-4208)
- Taiki Okumura (ORCID: https://orcid.org/0000-0001-5715-1748)
- Takeji Umemura (ORCID: https://orcid.org/0000-0001-7985-919X)
- Naoki Tanaka (ORCID: https://orcid.org/0000-0002-3212-3836)
- Takefumi Kimura (ORCID: https://orcid.org/0000-0002-1481-1029)
- Masayuki Kurosaki (ORCID: https://orcid.org/0000-0001-7016-8931)
- Hiroyuki Kobayashi (ORCID: https://orcid.org/0000-0002-6313-5549)
Institutions
- Shinshu University (JP)
- Shinshu University Hospital (JP)
- Musashino Red Cross Hospital (JP)
Publication Details
- Journal
- JGH Open
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1002/jgh3.70150
- Citations
- 7
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 9.48
Funders
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science